Andrew Gengos, See Below at Athira Pharma, Inc. (ATHA), bought 15,000 shares at $3.44 ($51K) on 2023-06-07, disclosed to the SEC on 2023-06-09.
Open-market purchase of $51k ATHA by See Below. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.36 | 422 | $1K | 2.8% |
| 2 | $3.40 | 2,859 | $10K | 18.9% |
| 3 | $3.44 | 11,719 | $40K | 78.4% |
| Total | $3.43 avg | 15,000 | $51K | 100% |
| Filing → |
| ATHA | SELL | 2024-09-05 | $725 | — | Filing → |
| ATHA | SELL | 2024-02-16 | $4K | — | Filing → |
| ATHA | SELL | 2024-01-08 | $4K | — | Filing → |